Shop by goal

Popular compounds

GHK-Cu Copper Peptide

GLP1-RC-RT

Research resources

Tesamorelin + Ipamorelin Blend peptide: Stacks research guide

In short: Tesamorelin and ipamorelin in one vial, in three strengths: 5 mg + 5 mg, 10 mg + 4 mg and 10 mg + 5 mg per vial. A GHRH(1-44) analogue paired with a selective ghrelin-receptor agonist. It is studied in preclinical (cell and animal) research and is supplied strictly for laboratory use, not for human or clinical use.

Not medical advice. Tesamorelin + Ipamorelin Blend is a research compound. This guide does not provide dosing, diagnosis, therapy recommendations, or claims about effects in humans.

Tesamorelin + Ipamorelin Blend at a glance

Compound type

Research peptide

Research category

Stacks

Also known as

tesamorelin ipamorelin blend, Tesa/Ipa blend, tesamorelin plus ipamorelin, GHRH 1-44 analogue plus ghrelin-receptor agonist, TI10, TI14, TI15

Evidence context

Preclinical / research use only

Regulatory status

Not an approved medicine. Supplied as a research compound

Last reviewed

14 October 2026

What to know first

Compound Tesamorelin + Ipamorelin Blend Research class Stacks Catalog code TI10 Available pack sizes 10 × 10 mg, 10 × 14 mg, 10 × 15 mg Storage Lyophilised powder: store in freezer (−20 °C). Reconstituted: refrigerate 1–6 °C, away from sunlight. Use within the validated stability window for the specific batch and formulation.

Details and limits sit in the sections below. Research use only. No unsupported scientific claims are added here.

What Tesamorelin + Ipamorelin Blend is

A research blend of tesamorelin and ipamorelin in three strengths (5 + 5, 10 + 4 and 10 + 5 mg per vial): a GHRH analogue and a selective ghrelin-receptor agonist in one vial.

One-paragraph overview from our research datasheet. Still scientific, but faster to read than the full mechanism list below.

Tesamorelin and ipamorelin in one vial, in three strengths: 5 mg + 5 mg, 10 mg + 4 mg and 10 mg + 5 mg per vial. A GHRH(1-44) analogue paired with a selective ghrelin-receptor agonist.

Research contexts

Peer-reviewed papers discuss Tesamorelin + Ipamorelin Blend in specific lab settings. The points below reflect research questions, not health claims.

Research vs. personal use: Literature describes experiments in cells and animals. That is distinct from real-world use. Our products are for laboratory research only.

Typical study contexts

Component peptides are usually characterised individually first; combination papers are less common.

Two growth-hormone-axis research peptides in one vial, in three strengths.

Strengths: 5 + 5 mg, 10 + 4 mg and 10 + 5 mg (10, 14 and 15 mg per vial).

Tesamorelin: GHRH(1-44) analogue with a trans-3-hexenoyl N-terminal modification.

Ipamorelin: pentapeptide characterised as a selective growth hormone secretagogue.

Why Stacks research matters

Stack products combine research peptides. Guides note how components are usually studied alone first.

Mechanisms (technical review)

Our datasheet lists mechanistic themes from preclinical work. These are research endpoints, not health claims.

Two growth-hormone-axis research peptides in one vial, in three strengths

Strengths: 5 + 5 mg, 10 + 4 mg and 10 + 5 mg (10, 14 and 15 mg per vial)

Tesamorelin: GHRH(1-44) analogue with a trans-3-hexenoyl N-terminal modification

Ipamorelin: pentapeptide characterised as a selective growth hormone secretagogue

The ratio differs by strength and is shown beside each printed vial code

Both compounds are also sold on their own, so the blend can be benchmarked against its parts

Lab handling & preparation

Storage: Lyophilised powder: store in freezer (−20 °C). Reconstituted: refrigerate 1–6 °C, away from sunlight. Use within the validated stability window for the specific batch and formulation.. See the storage guide.

Published pharmacokinetic context: Laboratory research material. No amount, schedule or administration guidance is published or recommended on this page.

Purity check: Use the COA reading guide and the published Certificates of Analysis (no current certificate is listed for Tesamorelin + Ipamorelin Blend yet).

Common Questions People Are Asking

What strengths does the tesamorelin + ipamorelin blend come in?

Three, chosen from the pack-size menu: 10 mg per vial (5 mg tesamorelin + 5 mg ipamorelin, code TI10), 14 mg (10 + 4, TI14) and 15 mg (10 + 5, TI15). The ratio is not the same in each.

Is this the approved tesamorelin medicine?

No. Tesamorelin is the active ingredient of an approved prescription medicine for a specific condition, but the material supplied here is unapproved laboratory research material and is not that product.

Why are tesamorelin and ipamorelin paired?

They act on the same pituitary cell type through different receptors, tesamorelin at the GHRH receptor and ipamorelin at a ghrelin-type receptor. That is the rationale for studying them together. This page cites no study of the fixed blend.

Is there human data on this blend?

No study of the blend is cited. The human trials in the references are of tesamorelin alone in specific patient groups. This is laboratory research material, sold strictly for in-vitro and preclinical research and not for human or veterinary use.

Is this page medical advice? Can I use Tesamorelin + Ipamorelin Blend for my health?

No, and no. This article is educational only. We do not provide dosing, medical recommendations, or health claims. Our products are sold strictly for laboratory research, not for personal use of any kind.

Where do I find Tesamorelin + Ipamorelin Blend specs, purity certificates and pricing?

Open the shop listing via “View product details.” There you will see concentration, purity grade, and available SKUs with current pricing. No current Certificate of Analysis is published for Tesamorelin + Ipamorelin Blend yet; published certificates are listed at /coa.

Related peptide guides

Other compounds researchers often read about alongside Tesamorelin + Ipamorelin Blend.

Tesamorelin: HGH / Somatropin research guide

Ipamorelin: HGH / Somatropin research guide

CJC-1295 (No DAC) + Ipamorelin Blend: Stacks research guide

CJC-1295 (without DAC): HGH / Somatropin research guide

Continue Tesamorelin + Ipamorelin Blend research

Analytical evidence, comparisons and current research for this compound. Research use only.

Research area Growth hormone secretagogue research The GH-axis research area - GHRH analogues and ghrelin-receptor agonists studied for their effect on pulsatile growth-hormone secretion. Explore the research area →

Scientific sources & further reading

Primary literature and registries for Tesamorelin + Ipamorelin Blend, plus mainstream coverage of the peptide category. Research use only - not medical advice.

Databases & literature:

PubMed: peer-reviewed literature on Tesamorelin + Ipamorelin Blend

ClinicalTrials.gov: registered studies on Tesamorelin + Ipamorelin Blend

Tesamorelin + Ipamorelin Blend: Wikipedia (search)

Peptides in the news:

WebMD: consumer health reference

BBC News: Health

CNN Health: “Peptides: what to know about the wellness trend”

Sky News: “Can peptides make America healthy again?”

Sky News: “Inside the exploding US peptides craze” (video)

Sky News Australia: “Black market peptide trade explodes as influencers fuel uptick in use”

Sky News Australia: “Backyard peptide boom sparks alarm” (video)

Sky News Australia: “Oprah reveals struggle with shame of weight-loss drugs”

Ready to order? View full product specs

Access concentration, batch info, variants, and current pricing on our shop.

Also known as: tesamorelin ipamorelin blend, Tesa/Ipa blend, tesamorelin plus ipamorelin, GHRH 1-44 analogue plus ghrelin-receptor agonist, TI10, TI14, TI15

PRECISION. PURITY. PERFORMANCE.

Research peptides. Third-party Certificates of Analysis (Janoshik Analytical & Freedom Diagnostics) are published on the website. Supplied strictly for laboratory research use.

Shop

All research compounds

Price list

Where to buy peptides

Research